R.D. Lovett

1.0k total citations
9 papers, 251 citations indexed

About

R.D. Lovett is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Dermatology. According to data from OpenAlex, R.D. Lovett has authored 9 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Dermatology. Recurrent topics in R.D. Lovett's work include Prostate Cancer Diagnosis and Treatment (3 papers), Prostate Cancer Treatment and Research (3 papers) and MRI in cancer diagnosis (2 papers). R.D. Lovett is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (3 papers), Prostate Cancer Treatment and Research (3 papers) and MRI in cancer diagnosis (2 papers). R.D. Lovett collaborates with scholars based in United States, Canada and Ireland. R.D. Lovett's co-authors include Susan J. Shapiro, Carlos A. Pérez, Delia M. Garcia, John Lister‐James, Thomas Hill, B.L. Holman, Perry W. Grigsby, H. Marvin Camel, Andrew E. Galakatos and Carlos A. Perez and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and American Journal of Clinical Oncology.

In The Last Decade

R.D. Lovett

9 papers receiving 240 citations

Peers

R.D. Lovett

EPIDE

DERMA

ONCOL

PRM

SURGE

Christina Parsons Canada

S.K. Chennupati United States

Janjira Petsuksiri Thailand

Gaëtan De Rauglaudre France

Piotr Wojcieszek Poland

Koichi Yamaguchi Japan

Valentina Caputo Italy

C. Patrick Hybarger United States

Fred Röhner Germany

Meredith Johnston Australia

Christina Parsons Canada

R.D. Lovett

48 ×0.3

EPIDE

44 ×0.5

DERMA

72 ×0.8

ONCOL

35 ×0.7

PRM

46 ×1.2

SURGE

Citations per year, relative to R.D. Lovett R.D. Lovett (= 1×) peers Christina Parsons

Countries citing papers authored by R.D. Lovett

Since Specialization

Citations

This map shows the geographic impact of R.D. Lovett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.D. Lovett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.D. Lovett more than expected).

Fields of papers citing papers by R.D. Lovett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.D. Lovett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.D. Lovett. The network helps show where R.D. Lovett may publish in the future.

Co-authorship network of co-authors of R.D. Lovett

This figure shows the co-authorship network connecting the top 25 collaborators of R.D. Lovett. A scholar is included among the top collaborators of R.D. Lovett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.D. Lovett. R.D. Lovett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Jackson, Will, Ming Tang, Matthew J. Schipper, et al.. (2022). Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601. Journal of Clinical Oncology. 40(27). 3172–3179. 12 indexed citations

Shipley, William U., Stephanie L. Pugh, Himu Lukka, et al.. (2016). NRG Oncology/RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA.. Journal of Clinical Oncology. 34(2_suppl). 3–3. 9 indexed citations

Lovett, R.D.. (2015). Treatment of bone metastases in a rural setting: The effect of Choosing Wisely.. Journal of Clinical Oncology. 33(29_suppl). 133–133. 1 indexed citations

Shipley, William U., Wendy Seiferheld, Himu Lukka, et al.. (2015). Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA. International Journal of Radiation Oncology*Biology*Physics. 94(1). 3–3. 14 indexed citations

Lovett, R.D., Carlos A. Pérez, Susan J. Shapiro, & Delia M. Garcia. (1990). External irradiation of epithelial skin cancer. International Journal of Radiation Oncology*Biology*Physics. 19(2). 235–242. 146 indexed citations

Kuske, Robert R., Carlos A. Perez, Perry W. Grigsby, et al.. (1989). Phase I/II Study of Definitive Radiotherapy and Chemotherapy (Cisplatin and 5-Fluorouracil) for Advanced or Recurrent Gynecologic Malignancies. American Journal of Clinical Oncology. 12(6). 467–473. 26 indexed citations

Lovett, R.D., et al.. (1989). Irradiation of epithelial skin cancer. International Journal of Radiation Oncology*Biology*Physics. 17. 167–167. 1 indexed citations

Lovett, R.D., Robert R. Kuske, Carlos A. Perez, et al.. (1987). Preliminary evaluation of toxicity and tumor response to radiotherapy with cis-platinum and 5-fluorouracil for advanced or recurrent gynecologic malignancies. International Journal of Radiation Oncology*Biology*Physics. 13. 129–130. 3 indexed citations

Holman, B.L., et al.. (1984). A comparison of two cerebral perfusion tracers, N-isopropyl I-123 p-iodoamphetamine and I-123 HIPDM, in the human.. PubMed. 25(1). 25–30. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact